April 2025 | Volume 24 | Issue 4 | 413 | Copyright April 2025 Published online March 7, 2025 doi:10.36849/JDD.8605 Sophia Daniel BS a,b , Stephanie Waggett BS a,c , Elliott Lyles BS a , Pelin Sagut MD a,d , Parisa Shamaei Zadeh MSPH b , Anthony Marcelletti BHS b , Carol Stegura ME c , Lara Wine Lee MD PhD d a College of Graduate Studies, Medical University of South Carolina, Charleston, SC b College of Medicine, University of Kentucky, Lexington, KY c College of Medicine, Medical University of South Carolina, Charleston, SC d Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC Abstract Glucagon-like peptide-1 (GLP-1) agonists are used to treat type 2 diabetes mellitus (T2DM) and have recently gained approval and popularity for treating obesity and weight loss
This constant degranulation generates even more free radicals, which in turn causes more oxidative stress, further depleting the remaining glutathione
The parasite uptake triggers an almost immediate increase in the expression of inflammatory cytokines followed by delayed and subpar production of O 2 and NO in macrophages (Koo et al., 2018)
Our L-Carnitine Base is produced through an advanced chemical synthesis process involving chiral separation to ensure optical purity, followed by multiple purification steps and crystallization
The result is reduced potency and potentially altered pharmacokinetics